Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five years of an Alongside Midwifery Unit at a Swiss Perinatal Centre: a retrospective descriptive study.

Swiss medical weekly·2026
Same author

Association of glomerular hyperfiltration with mortality in stroke: an analysis using pooled individual patient data.

European stroke journal·2026
Same author

Incidence of multiple sclerosis in Switzerland - results from the Swiss multiple sclerosis registry.

Multiple sclerosis and related disorders·2026
Same author

Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial.

The Lancet. Neurology·2026
Same author

Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis Registry.

BMJ neurology open·2026
Same author

Pure agraphia following a focal lesion in exner's area: a case study supporting the dual-route and network models of writing.

BMC neurology·2026
Same journal

Explainable machine learning-based preliminary screening for viral encephalitis by blood routine analysis.

Frontiers in neurology·2026
Same journal

Global landscape of registered clinical trials of stem cell therapy for spinal cord injury: a cross-sectional analysis.

Frontiers in neurology·2026
Same journal

Experimental verification and PK/PD modeling of selective drug absorption via acupoint administration in rabbit model of rheumatoid arthritis.

Frontiers in neurology·2026
Same journal

Plasma metabolomic signatures of the no-reflow phenomenon in stroke patients following thrombectomy.

Frontiers in neurology·2026
Same journal

Parametric color-coding-derived microvascular transit time may predict infarction and reveals microcirculatory benefits of Tenecteplase in acute ischemic stroke.

Frontiers in neurology·2026
Same journal

The application of fNIRS-sEMG in the study of muscle-brain coupling.

Frontiers in neurology·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

17.4K

Behavioral Changes in Patients with Multiple Sclerosis.

Mirjam R Heldner1, Sigal Kaufmann-Ezra2, Klemens Gutbrod2

  • 1Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Frontiers in Neurology
|September 13, 2017
PubMed
Summary
This summary is machine-generated.

Behavioral changes are common in multiple sclerosis (MS) patients, affecting up to one-third. These changes correlate with fatigue and depression, not disease severity or disability, and warrant specific testing.

Keywords:
Frontal Systems Behavior Scalebehavioral changescognitiondisability evaluationmultiple sclerosis

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.7K

Related Experiment Videos

Last Updated: Feb 23, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

17.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.7K

Area of Science:

  • Neurology
  • Neuropsychology

Background:

  • Behavioral changes are frequently observed in multiple sclerosis (MS) patients but often overlooked compared to cognitive deficits.
  • Recognizing these behavioral alterations is crucial for comprehensive patient care.

Purpose of the Study:

  • To investigate the prevalence of behavioral changes in MS patients.
  • To analyze the relationship between behavioral changes and disease characteristics, physical disability, and cognitive impairments in MS.

Main Methods:

  • A cross-sectional study involving 66 MS patients.
  • Neuropsychological assessment using the Frontal Systems Behavior Scale (FrSBe), Beck Depression Inventory (BDI), and Wuerzburg Fatigue Inventory for Multiple Sclerosis (WEIMuS).
  • Correlation analysis of FrSBe scores with clinical and cognitive data.

Main Results:

  • Approximately one-third of MS patients exhibited behavioral changes.
  • Behavioral changes were associated with fatigue and depressive symptoms (BDI, WEIMuS).
  • No significant correlation was found between behavioral changes and disease duration, physical disability (Expanded Disability Status Scale), or cognitive function.

Conclusions:

  • Behavioral changes are prevalent in MS, even in mildly affected individuals.
  • These changes are largely independent of disease characteristics and disability but linked to fatigue and depression.
  • Specific screening for behavioral changes in MS patients is recommended.